Featured Articles

OVH Launches Its Latest Xeon Range: HG 2009 Customized Servers

OVH Launches Its Latest Xeon Range: HG 2009 Customized Servers

Feb 24 2009 | comment(s)

ROUBAIX, France, February 24 /PRNewswire/ -- OVH, the leading French hosting service, is launching a top of the range system designed for professionals with key requirements in terms of resources, performance and also service-sharing. Covering a wide range of prices, and corresponding services, the HG range consists of the ultimate in customized servers to meet company requirements.

Meeting customers' most critical needs

In marketing its new range, OVH is innovating yet again, as the HG 2009 consists of fully-customizable servers. This means that customers can customize the configuration of their servers:

International Partnership For Microbicides Receives US $130 Million From UK Government And The Gates Foundation

International Partnership For Microbicides Receives US $130 Million From UK Government And The Gates Foundation

Feb 24 2009 | comment(s)

SILVER SPRING, Maryland, February 24 /PRNewswire/ --

- New support will accelerate development of new tools to help women protect themselves from HIV

The International Partnership for Microbicides (IPM) announced today that it has received a total of US $130 million in grants from the UK Department for International Development (DFID) and the Bill Melinda Gates Foundation, reinforcing the global commitment to address the HIV epidemic in women.

Critical Thinking Skills - The Cure For Anti-Intellectualism

Critical Thinking Skills - The Cure For Anti-Intellectualism

Feb 24 2009 | comment(s)

Over at the Chronicle of Higher Education, Columbia University humanities professor Andrew Delbanco takes stock of recent arguments that the intellectuals are back in charge of government:

What goes on here? Was the historian Richard Hofstadter wrong in his classic Anti-Intellectualism in American Life to detect an irresistible current in our society of "resentment and suspicion of the life of the mind and of those who are considered to represent it"? Has that current weakened or been sufficiently dammed up to explain the election of a president who is reflective about history and ideas as well as about policy and practice?
Lamit Company Launches A New Network Solution For Improving The Internet Connection

Lamit Company Launches A New Network Solution For Improving The Internet Connection

Feb 24 2009 | comment(s)

BUCHAREST, February 24 /PRNewswire/ -- Lamit Company, an important satellite internet provider, launches a new solution for improving the satellite internet connections (terrestrial, wireless or bidirectional via satellite), the 2.5 STABLE version of Lamit 2Pro Advanced and Lamit 2Pro Mini Power servers. Despite the very small dimensions of the Mini Power server, it maintains all the features and characteristics of the Lamit 2Pro server's Platform. The new generation of servers includes Wireless connectivity (N type, offering an extended coverage area and maximum transfer rates) providing easier users' connection. The new servers' version also offers new encryption facilities, a better control and professional management of the users' LAN.

Luminary Micro Offers A Free IEC 60730 Library Addition To StellarisWare

Luminary Micro Offers A Free IEC 60730 Library Addition To StellarisWare

Feb 24 2009 | comment(s)

AUSTIN, Texas, February 24 /PRNewswire/ --

- Specifically for use with Stellaris Microcontrollers, New Software Library Provides Appliance OEMs a Fast Path to Best-in-Class Safety Compliance

PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement With Merck Eprova AG To Utilize Merck Eprova's Enantiomers Of DOTAP Chloride In Immunotherapies

PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement With Merck Eprova AG To Utilize Merck Eprova's Enantiomers Of DOTAP Chloride In Immunotherapies

Feb 24 2009 | comment(s)

INDIANAPOLIS, February 24 /PRNewswire/ --

PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) technology. The use of enantiomerically pure DOTAP Chloride shows enhanced adjuvant activity compared to the racemate. Merck Eprova AG will be providing enantiomerically pure DOTAP Chloride manufactured under cGMP for use in clinical and commercial drug products developed with PDS Biotechnology's Versamune(TM) nanoparticle technology. PDS Biotechnology will own the intellectual property rights to products incorporating the chiral DOTAP lipids for immunotherapeutic applications.

Evidence Mishandled: Meat-Eating Killer Tracked To Africa

Evidence Mishandled: Meat-Eating Killer Tracked To Africa

Feb 24 2009 | comment(s)

New evidence of a carnivorous killer has been found in Africa. This ancient killer almost had the misfortune of going extinct twice.

While evidence of 95-million year old therapods from Africa is quite scare making one think that each fragment would be treated like gold, this was not the case the first evidence of Carcharodontosaurus iguidensis, a newly described dinosaur from the Cenomanian of Nigeria and published in the December 2007 issue of the Journal of Vertebrate Paleontology.




Blogosphere Beats Peer Review Finding Stealth Creationist Paper

Blogosphere Beats Peer Review Finding Stealth Creationist Paper

Feb 24 2009 | comment(s)

Academia is notoriously resistant to change, which to some extent is a good thing. It was therefore no surprise that when Wikipedia became a phenomenon most academics scoffed at it as a passing fad, fatally flawed by its very core idea: anybody, and I mean anybody, can become a Wiki author and post new entries or edit existing ones. Surely, this will inevitably lead to chaos and complete unreliability, the critics said.
China's 3G Buildout To Drive A Telecom Capex Increase In Asia/Pacific, Pyramid Research Reports

China's 3G Buildout To Drive A Telecom Capex Increase In Asia/Pacific, Pyramid Research Reports

Feb 24 2009 | comment(s)

CAMBRIDGE, Massachusetts, February 24 /PRNewswire/ --

Despite an overall economic contraction, network operator spending on telecom equipment in the Asia/Pacific region will rise slightly over the next 24 months, driven primarily by deployment of 3G networks in China, according to a new report from Pyramid Research (http://www.pyr.com), the telecom research arm of the Light Reading Communications Network (http://www.lightreading.com ).

Merck Serono And Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

Merck Serono And Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

Feb 24 2009 | comment(s)

GENEVA, February 24 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and Ambrx Inc, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by Ambrx through the application of its proprietary protein optimization technology, ReCODE(TM).

This second collaboration between the two companies follows a previous agreement announced in 2007 to develop ARX201, Ambrx's long-acting growth hormone product, currently in Phase II of clinical development.

Eiger BioPharmaceuticals Raises US$7.1 Million 'A' Round

Eiger BioPharmaceuticals Raises US$7.1 Million 'A' Round

Feb 24 2009 | comment(s)

PALO ALTO, California, February 24 /PRNewswire/ --

- Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets

Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised US$7.1 million in a Series A financing co-led by InterWest Partners and Vivo Ventures. The two firms were instrumental in the formation of the company and recruitment of its team and are represented on the board of directors by general partners Nina Kjellson and Dr. Edgar Engelman, respectively. The funding will advance the company's lead program targeted against NS4B, a specific region in the hepatitis C virus (HCV) protein, as well as progress lead identification for other proprietary targets.

Marvell Introduces Plug Computing - High-Performance, Low-Power, Exceptionally Small Computer For Managing And Storing Digital Media Assets

Marvell Introduces Plug Computing - High-Performance, Low-Power, Exceptionally Small Computer For Managing And Storing Digital Media Assets

Feb 24 2009 | comment(s)

SANTA CLARA, California, February 24 /PRNewswire/ --

- Multiple companies adopt SheevaPlug(TM) development platform to showcase new network-based applications that are designed to be simple to install and easy to use

Marvell (Nasdaq: MRVL) today announced its Plug Computing initiative to make high-performance, always on, always connected, and environmentally friendly computing readily available for developers and end-users. A Plug Computer is small enough to plug directly into a wall socket and is designed to draw so little power that it can be left on all of the time. Unlike other embedded devices in the home, it contains a gigahertz class processor to offer PC class performance. This makes it a viable alternative to a PC for any software service.

Altira Takes Leadership Role In The National Energy Debate, Sponsors Provocative Panel Discussion Debunking 'Dirty' Energy Myths At CleanTech XXI

Altira Takes Leadership Role In The National Energy Debate, Sponsors Provocative Panel Discussion Debunking 'Dirty' Energy Myths At CleanTech XXI

Feb 24 2009 | comment(s)

DENVER, February 24 /PRNewswire/ --

Altira Group LLC - a pioneer and leader in venture capital and private equity funding for energy technology companies, today announced it will be hosting a thought-leadership panel, Debunking Dirty Technology Myths: From Campaign Rhetoric to Action at CleanTech XXI in San Francisco on Tuesday February 24, 2009 at 3:30pm PST.

This interactive session will examine the controversial topics of nuclear energy, clean coal, and hydrocarbons, contesting current popular myths based on decades-old information. The panel will demonstrate why these energy sources are required to meet growing energy demand today, and how technology gains and efficiencies have dramatically advanced their benefits.

Computershare Governance Services Wins Prestigious StatoilHydro Contract

Computershare Governance Services Wins Prestigious StatoilHydro Contract

Feb 24 2009 | comment(s)

BRISTOL, England, February 24 /PRNewswire/ -- Computershare Governance Services (CGS), part of the Computershare group of companies (ASX:CPU) has won a prestigious contract to supply Norwegian company StatoilHydro with its Global Entity Management System (GEMS).

Created in 2007 from the merger of Statoil and Hydro's oil and gas activities, the company has approximately 29,500 employees in 40 countries, and is the operator for 39 producing oil and gas fields.

CGS won the contract following a rigorous procurement process, including requiring providers to achieve accreditation to Achilles Joint Qualification System, the database used by Norwegian and Danish gas and oil operators when selecting suppliers.

Babylon Ltd., The International Leading Provider Of Translation And Dictionary Software Company, Ranks No. 1 And Took The TopTenREVIEWS Gold Award

Babylon Ltd., The International Leading Provider Of Translation And Dictionary Software Company, Ranks No. 1 And Took The TopTenREVIEWS Gold Award

Feb 24 2009 | comment(s)

NEW YORK, February 24 /PRNewswire/ -- Babylon LTD (TASE: BBYL), a world leading provider of online and offline dictionary and translation solutions, has ranked No. 1 in the review of the 2009 translation software carried out by TopTen Reviews and ranked above the competition and took the TopTenREVIEWS Gold Award http://translation-software-review.toptenreviews.com/babylon-6-review.html .

Alcatel-Lucent Enters Relationship With BT Global Services To Help Organisations Secure Data On Mobile Employees' Laptops

Alcatel-Lucent Enters Relationship With BT Global Services To Help Organisations Secure Data On Mobile Employees' Laptops

Feb 24 2009 | comment(s)

PARIS, February 24 /PRNewswire/ --

- 'Laptop Protection From BT MobileXpress', Powered by Alcatel-Lucent, Simplifies the Security and Management of Mobile Computers

Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced a strategic relationship with BT Global Services, a world-leading provider of networked IT services.

Mindset BioPharmaceuticals (USA) Inc Obtains Notice Of Allowance For European Patent Related To Use Of Insulin Sensitizers In Senile Dementia, Dementia And Memory Loss

Mindset BioPharmaceuticals (USA) Inc Obtains Notice Of Allowance For European Patent Related To Use Of Insulin Sensitizers In Senile Dementia, Dementia And Memory Loss

Feb 24 2009 | comment(s)

NEW YORK, February 24 /PRNewswire/ --

Frost Sullivan: Novel Diagnostics Methods Driving The European Cancer IVD Market Towards Early Detection And Prevention

Frost Sullivan: Novel Diagnostics Methods Driving The European Cancer IVD Market Towards Early Detection And Prevention

Feb 24 2009 | comment(s)

LONDON, February 24 /PRNewswire/ --

Early detection is the key focus of cancer diagnostics. Traditional testing methods such as immunoassay testing are facing fierce competition from evolving segments such as nucleic acid amplification technology (NAT) and immunohistochemistry testing. The ability to prove the clinical utility and practical use of the test within a laboratory is one of the essential requirements to be successful in this market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost Sullivan (http://www.drugdiscovery.frost.com), European Cancer IVD Market, finds that the market earned revenues of $623.5 million in 2008 and estimates this to reach $1.5 billion in 2015.

Google Ranked Strongest UK Business Superbrand 2009

Google Ranked Strongest UK Business Superbrand 2009

Feb 24 2009 | comment(s)

LONDON, February 24 /PRNewswire/ --

- As British Airways and BBC Worldwide Fall Out of the Top 10

Internet giant Google has - for the second year in a row - notched the top slot in the prestigious annual Business Superbrands survey, compiled by The Centre for Brand Analysis (TCBA) on behalf of the Superbrands organisation. To generate the rankings TCBA analysed the views of an Expert Council and over 1,500 business professionals.

Heptares Secures GBP21 Million In Series A Fund Raising To Accelerate Development Of Pipeline Of Small Molecules Against High-Value GPCR Drug Targets

Heptares Secures GBP21 Million In Series A Fund Raising To Accelerate Development Of Pipeline Of Small Molecules Against High-Value GPCR Drug Targets

Feb 24 2009 | comment(s)

LONDON, February 24 /PRNewswire/ --

- Syndicate Comprises Leading Sector Investors Clarus Ventures, MVM Life Science Partners and Novartis Option Fund

Heptares Therapeutics Ltd, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), announces today it has raised GBP21 million (US$30 million) of equity finance in a successful Series A private round from three blue-chip international venture capital firms. Clarus Ventures led the syndicate, which includes the founding investor, MVM Life Science Partners, and the Novartis Option Fund. All three investors contributed equally.